Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.22.61 (
caspase-8
)
6,833
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
There is abundant evidence that Retinoblastoma (Rb) activity is important in the control of cell proliferation and apoptosis. Reversible phosphorylation of the Rb protein that is carried out by cyclin dependent kinases and Protein phosphatase 1 (PP1) regulates its functions. A PP1 interacting protein,
PNUTS
(Phosphatase Nuclear Targeting Subunit) is proposed to be a regulator of Rb phosphorylation. In this study,
PNUTS
knockdown in MCF7, SKA and HCT116 cancer cells causes a reduction in viability due to increased apoptosis. However, normal cells (MCF10A breast and CCD-18Co colon) do not exhibit reduced viability when
PNUTS
expression is diminished.
PNUTS
knockdown has no effect in Rb-null Saos-2 cells. However, when Rb is stably expressed in Saos-2 cells,
PNUTS
knockdown reduces cell number. Knockdown of
PNUTS
in p53-/- HCT116 cells indicates that p53 is dispensable for the induction of apoptosis. Loss of
PNUTS
expression results in increased Rb-phosphatase activity and Rb dephosphorylation. E2F1 dissociates from Rb in cells depleted of
PNUTS
and the resulting apoptosis is dependent on
caspase-8
. These results indicate that Rb phosphorylation state can be manipulated by targeting Rb phosphatase activity and suggest that
PNUTS
may be a potential target for therapeutic pro-apoptotic strategies.
...
PMID:Reduced expression of PNUTS leads to activation of Rb-phosphatase and caspase-mediated apoptosis. 1849 66